Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest: a meta-analysis

Ashleigh Xie, Kevin Phan, Mbbs Yi-Chin Tsai, Tristan D. Yan*, Paul Forrest

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

99 Citations (Scopus)


Objective To evaluate the effect of extracorporeal membrane oxygenation (ECMO) on survival and complication rates in adults with refractory cardiogenic shock or cardiac arrest. Design Meta-analysis. Setting University hospitals. Participants One thousand one hundred ninety-nine patients from 22 observational studies. Interventions None. Measurements and Main Results Observational studies published from the year 2000 onwards, examining at least 10 adult patients who received ECMO for refractory cardiogenic shock or cardiac arrest were included. Pooled estimates with 95% confidence intervals were calculated based on the Freeman-Tukey double-arcsine transformation and DerSimonian-Laird random-effect model. Survival to discharge was 40.2% (95% confidence intervals [CI], 33.9-46.7), while survival at 3, 6, and 12 months was 55.9% (95% CI, 41.5-69.8), 47.6% (95% CI, 25.4-70.2), and 54.4% (95% CI, 36.6-71.7), respectively. Survival up to 30 days was higher in cardiogenic shock patients (52.5%, 95% CI, 43.7%-61.2%) compared to cardiac arrest (36.2%, 95% CI, 23.1%-50.4%). Concurrently, complication rates were particularly substantial for neurologic deficits (13.3%, 95% CI, 8.3-19.3), infection (25.1%, 95%CI, 15.9-35.5), and renal impairment (47.4%, 95% CI, 30.2-64.9). Significant heterogeneity was detected, although its levels were similar to previous meta-analyses that only examined short-term survival to discharge. Conclusions Venoarterial ECMO can improve short-term survival in adults with refractory cardiogenic shock or cardiac arrest. It also may provide favorable long-term survival at up to 3 years postdischarge. However, ECMO also is associated with significant complication rates, which must be incorporated into the risk-benefit analysis when considering treatment. These findings require confirmation by large, adequately controlled and standardized trials with long-term follow-up.

Original languageEnglish
Pages (from-to)637-645
Number of pages9
JournalJournal of Cardiothoracic and Vascular Anesthesia
Issue number3
Publication statusPublished - 1 Jun 2015


  • cardiogenic shock
  • cardiac arrest
  • extracorporeal membrane oxygenation
  • extracorporeal circulation
  • meta-analysis
  • adult


Dive into the research topics of 'Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest: a meta-analysis'. Together they form a unique fingerprint.

Cite this